F10 |
F10: Coagulation factor X precursor |
CSF3R |
IPI00216365 |
34.910 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
34.910 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
PLAU |
Plasminogen activator, urokinase |
34.910 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
34.910 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
PLAU |
Plasminogen activator, urokinase |
34.910 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
34.880 |
Evidence |
|
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
PLEKHA5 |
PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member |
34.880 |
Evidence |
|
FGA |
IPI00021885 |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
34.880 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
PRKAA1 |
IPI00011891 |
34.880 |
Evidence |
|
HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
WDR1 |
IPI00556374 |
34.880 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
IRS2 |
IRS2: Insulin receptor substrate 2 |
34.880 |
Evidence |
|
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
34.880 |
Evidence |
|
RELA |
RELA, NFKB3: Transcription factor p65 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
34.880 |
Evidence |
|
S100B |
S100B: Protein S100-B |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
34.880 |
Evidence |
|
DSG3 |
DSG3: Desmoglein-3 precursor |
DSG2 |
DSG2: Desmoglein-2 precursor |
34.880 |
Evidence |
|
WASPIP |
IPI00552369 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
34.880 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
34.880 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
34.880 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
34.880 |
Evidence |
|
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
34.860 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
GTF2F2 |
IPI00329767 |
34.860 |
Evidence |
O
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
34.860 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
34.860 |
Evidence |
|
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
34.860 |
Evidence |
|
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
34.860 |
Evidence |
|